Summary
My aim is to understand the exact genetic contribution in every patient with Amyotrophic Lateral Sclerosis (ALS), a lethal disease with a life time risk of 0.3% and an urgent unmet therapeutic need. Technological advances have enabled the development of gene-based therapies as...
More information & hyperlinks